IL221619A - Preparations and methods for increasing fat implant absorption - Google Patents
Preparations and methods for increasing fat implant absorptionInfo
- Publication number
- IL221619A IL221619A IL221619A IL22161912A IL221619A IL 221619 A IL221619 A IL 221619A IL 221619 A IL221619 A IL 221619A IL 22161912 A IL22161912 A IL 22161912A IL 221619 A IL221619 A IL 221619A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- graft survival
- fat graft
- enhancing fat
- Prior art date
Links
- 230000002708 enhancing effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000004083 survival effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Surgery (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30699110P | 2010-02-23 | 2010-02-23 | |
| PCT/IL2011/000181 WO2011104707A1 (en) | 2010-02-23 | 2011-02-23 | Methods and compositions for enhancing fat graft survival |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL221619A true IL221619A (en) | 2017-09-28 |
Family
ID=44506187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL221619A IL221619A (en) | 2010-02-23 | 2012-08-23 | Preparations and methods for increasing fat implant absorption |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20120315254A1 (enExample) |
| EP (1) | EP2539443B1 (enExample) |
| JP (2) | JP5823986B2 (enExample) |
| CN (1) | CN102906250A (enExample) |
| AU (1) | AU2011219425A1 (enExample) |
| BR (1) | BR112012021179A2 (enExample) |
| CA (1) | CA2790867A1 (enExample) |
| IL (1) | IL221619A (enExample) |
| IN (1) | IN2012MN02218A (enExample) |
| MX (1) | MX2012009768A (enExample) |
| RU (1) | RU2012140379A (enExample) |
| WO (1) | WO2011104707A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011219425A1 (en) * | 2010-02-23 | 2012-10-18 | Sebana Medical Ltd. | Methods and compositions for enhancing fat graft survival |
| JP5953035B2 (ja) * | 2011-11-28 | 2016-07-13 | 学校法人慶應義塾 | 病理診断支援装置、病理診断支援方法、及び病理診断支援プログラム |
| CN107456606A (zh) * | 2017-08-30 | 2017-12-12 | 上海新肌生物科技有限公司 | 一种脂肪细胞存活率提高91%的复活素配方及制备方法 |
| CN110229785A (zh) * | 2019-06-17 | 2019-09-13 | 白晋 | 一种利用血管内皮祖细胞提升脂肪移植成功率的方法 |
| CN111548988B (zh) * | 2020-05-14 | 2023-06-20 | 江苏芝海生物科技有限公司 | 一种医用漂洗液及其制备方法和应用 |
| CA3200227A1 (en) * | 2020-11-25 | 2022-06-02 | Alexandra Sophie DE BOER | Adipogenic cell compositions and methods |
| CN113413177B (zh) * | 2021-06-23 | 2022-08-02 | 美闺(长沙)医疗美容有限公司 | 一种保持自体脂肪活性的移植设备及控制方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8105580B2 (en) | 2001-12-07 | 2012-01-31 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to promote wound healing |
| US7651684B2 (en) * | 2001-12-07 | 2010-01-26 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| US7459152B2 (en) * | 2003-04-23 | 2008-12-02 | Rush University Medical Center | Erythropoietin administration to improve graft survival |
| BRPI0411621A (pt) * | 2003-06-18 | 2006-08-08 | Macropore Biosurgery Inc | métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga |
| PT1699915E (pt) * | 2003-12-30 | 2010-08-31 | Augustinus Bader | Utilização de eritropoietina para a regeneração de tecido hepático |
| ITPD20050168A1 (it) * | 2005-06-01 | 2006-12-02 | Fidia Advanced Biopolymers Srl | Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico |
| JP5039715B2 (ja) * | 2006-01-24 | 2012-10-03 | ブラウン ユニバーシティ | 細胞凝集及び封入デバイス及び方法 |
| WO2008019434A1 (en) | 2006-08-14 | 2008-02-21 | Victorian Tissue Engineering Pty Ltd | The use of growth factors in a method of improving fat-graft survival |
| EP2192907B1 (en) * | 2007-08-16 | 2018-04-18 | Remedor Biomed Ltd. | Erythropoietin and fibronectin compositions for therapeutic applications |
| AU2011219425A1 (en) * | 2010-02-23 | 2012-10-18 | Sebana Medical Ltd. | Methods and compositions for enhancing fat graft survival |
-
2011
- 2011-02-23 AU AU2011219425A patent/AU2011219425A1/en not_active Abandoned
- 2011-02-23 WO PCT/IL2011/000181 patent/WO2011104707A1/en not_active Ceased
- 2011-02-23 EP EP11746961.9A patent/EP2539443B1/en active Active
- 2011-02-23 RU RU2012140379/15A patent/RU2012140379A/ru unknown
- 2011-02-23 US US13/580,381 patent/US20120315254A1/en active Pending
- 2011-02-23 BR BR112012021179A patent/BR112012021179A2/pt not_active IP Right Cessation
- 2011-02-23 CA CA2790867A patent/CA2790867A1/en not_active Abandoned
- 2011-02-23 JP JP2012554466A patent/JP5823986B2/ja active Active
- 2011-02-23 CN CN2011800205877A patent/CN102906250A/zh active Pending
- 2011-02-23 MX MX2012009768A patent/MX2012009768A/es not_active Application Discontinuation
-
2012
- 2012-08-23 IL IL221619A patent/IL221619A/en active IP Right Grant
- 2012-09-20 IN IN2218MUN2012 patent/IN2012MN02218A/en unknown
-
2015
- 2015-10-08 JP JP2015200614A patent/JP6023864B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2539443A4 (en) | 2013-12-11 |
| RU2012140379A (ru) | 2014-03-27 |
| US20120315254A1 (en) | 2012-12-13 |
| EP2539443B1 (en) | 2019-03-27 |
| BR112012021179A2 (pt) | 2015-09-15 |
| IN2012MN02218A (enExample) | 2015-06-12 |
| JP6023864B2 (ja) | 2016-11-09 |
| AU2011219425A1 (en) | 2012-10-18 |
| EP2539443A1 (en) | 2013-01-02 |
| CA2790867A1 (en) | 2011-09-01 |
| CN102906250A (zh) | 2013-01-30 |
| MX2012009768A (es) | 2013-02-27 |
| JP2013520271A (ja) | 2013-06-06 |
| JP5823986B2 (ja) | 2015-11-25 |
| JP2016041261A (ja) | 2016-03-31 |
| WO2011104707A1 (en) | 2011-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2579819A4 (en) | IMPLANT COMPONENTS AND METHOD | |
| PH12013500698A1 (en) | Hair-mending compositions and associated methods | |
| EP2566930A4 (en) | COOLING COMPOSITIONS AND METHODS | |
| IL222316A0 (en) | Edible composition and uses thereof | |
| IL230237B (en) | Fat Cell Compounds and Methods | |
| PT3366143T (pt) | Composições e métodos probióticos | |
| EP2585574A4 (en) | AROMA COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF | |
| EP2585052A4 (en) | CONTROLLED RELEASE COMPOSITIONS HAVING REDUCED FOOD EFFECT | |
| SI2550018T1 (sl) | Sestavki in metode, uporabni za stabilizacijo formulacij, ki vsebujejo beljakovine | |
| EP2663635A4 (en) | MICROBIAL COMPOSITIONS AND METHOD THEREFOR | |
| ZA201209201B (en) | Cyclopropene compositions | |
| ZA201308705B (en) | Nutritional compositions for enhancing performance and methods for making and using same | |
| SG10201601858PA (en) | Methods and compositions that provide detergency | |
| PL2504353T5 (pl) | Kompozycje lipopeptydowe i związane metody | |
| ZA201303423B (en) | Compositions and methods for treating myelofibrosis | |
| EP2680837A4 (en) | COMPOSITIONS AND METHODS COMPRISING C16: 1N7-PALMITOLATE | |
| PL3586826T3 (pl) | Kompozycje i sposoby stabilizowania preparatów zawierających białka | |
| PL2584908T3 (pl) | Nietemperowane nadające teksturę kompozycje tłuszczowe | |
| IL221619A (en) | Preparations and methods for increasing fat implant absorption | |
| IL250307A0 (en) | Pesticide preparations and methods | |
| EP2621285A4 (en) | COMPOSITIONS AND METHODS FOR INCREASING RENAL FUNCTION | |
| ZA201308051B (en) | Nutritional compositions having reduced sodium content and methods for making same | |
| GB201018650D0 (en) | Methods and compositions | |
| ZA201308892B (en) | Compositions and methods | |
| GB0901494D0 (en) | Compositions and Methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |